The redox sensor KEAP1 facilitates adaptation of T cells to chronic antigen stimulation by preventing hyperactivation
Science Immunology · 29.11.2024 · 9 (101)
DOI: 10.1126/sciimmunol.adk2954 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 29.11.2024. Verfasst von Ziang Zhu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, NF-E2-Related Factor 2, Oxidation-Reduction, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
During persistent antigen stimulation, exhausted CD8 + T cells are continuously replenished by self-renewing stem-like T cells. However, how CD8 + T cells adapt to chronic stimulation remains unclear. Here, we show that persistent antigen stimulation primes chromatin for regulation by the redox-sensing KEAP1-NRF2 pathway. Loss of KEAP1 in T cells impaired control of chronic viral infection. T cell–intrinsic KEAP1 suppressed NRF2 to promote expansion and persistence of virus-specific CD8 + T cells, drive a stem-like T cell response, down-regulate immune checkpoint molecules, and limit T cell receptor (TCR) hyperactivation and apoptosis. NRF2 epigenetically derepressed BACH2 targets and opposed a stem-like program driven by BACH2. In exhausted T cells induced by tonic GD2 chimeric antigen receptor (CAR) signaling, the effects of KEAP1 deficiency were rescued by inhibiting proximal TCR signaling. Enhancing mitochondrial oxidation improved the expansion and survival of KEAP1-deficient CD8 + GD2 CAR T cells and up-regulated markers associated with stem-like cells. Thus, the KEAP1-NRF2 axis regulates stem-like CD8 + T cells and long-term T cell immunity during chronic antigen exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Immunology PhD Program, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
- Cancer Biology PhD Program, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Microbiology, Immunology, & Molecular Genetics, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
ORCID-Profile: Ziang Zhu, Kiddist Yihunie, Safuwra Wizzard, Andrew W DeVilbiss, Chaoyu Ma, Taidou Hu, Nu Zhang, Shyam Biswal, Ralph J DeBerardinis, Tuoqi Wu, Chen Yao
Förderung
- NIA NIH HHS
- NIAID NIH HHS
Zitieren
APA
Zhu, Z., Luo, Y., Lou, G., Yihunie, K., Wizzard, S., DeVilbiss, A. W., Muh, S., Ma, C., Shinde, S. S., Hoar, J., Hu, T., Zhang, N., Biswal, S., DeBerardinis, R. J., Wu, T., & Yao, C. (2024). The redox sensor KEAP1 facilitates adaptation of T cells to chronic antigen stimulation by preventing hyperactivation. Science Immunology, 9(101). https://doi.org/10.1126/sciimmunol.adk2954
Vancouver
Zhu Z, Luo Y, Lou G, Yihunie K, Wizzard S, DeVilbiss AW, et al. The redox sensor KEAP1 facilitates adaptation of T cells to chronic antigen stimulation by preventing hyperactivation. Science Immunology. 2024;9(101). doi:10.1126/sciimmunol.adk2954
BibTeX
@article{Zhu2024,
author = {Zhu, Ziang and Luo, Ying and Lou, Guohua and Yihunie, Kiddist and Wizzard, Safuwra and DeVilbiss, Andrew W and Muh, Sarah and Ma, Chaoyu and Shinde, Sejal S and Hoar, Jonathan and Hu, Taidou and Zhang, Nu and Biswal, Shyam and DeBerardinis, Ralph J and Wu, Tuoqi and Yao, Chen},
title = {The redox sensor KEAP1 facilitates adaptation of T cells to chronic antigen stimulation by preventing hyperactivation},
journal = {Science Immunology},
year = {2024},
volume = {9},
number = {101},
doi = {10.1126/sciimmunol.adk2954}
}
EUVIMED